- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04861623
Effects of 100% Orange Juice on Skin Health in Women
February 6, 2024 updated by: University of Florida
A Pilot Clinical Trial to Assess the Effects of 100% Orange Juice on Skin Health in Women Using a Randomized Double-Blinded Placebo-Controlled Crossover Design
Daily consumption of Orange Juice (OJ) protects skin against UV-induced damages and wrinkling, improves skin barrier function and overall skin health by decreasing oxidative stress, inflammation, and protein glycation.
The positive effects of OJ on skin appearance are associated with improvements of the stratum corneum lipidomic and skin microbiome.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
There is a lack of clinical evidence on how 100% orange juice (OJ) affects skin health.
Women make over 90% of the decisions on food purchases for family.
Skin health is a major concern for women because skin ageing becomes visibly noticeable after age 30 due to UV exposure, oxidative stress, and collagen glycation.
The investigators hypothesize that micronutrients in OJ, including vitamin C, flavanones, and carotenoids, protect skin against photoaging and wrinkling by alleviating oxidative stress, inflammation, and collagen glycation.
The investigators further propose that daily OJ consumption (16 oz) will improve skin elasticity, barrier function, overall skin appearance and health.
The study hypotheses will be tested in a 12-week clinical trial in 24 women aged 45-65 using a randomized, double-blinded, placebo-controlled, crossover design.
Placebo will be formulated using decarbonated Fanta® orange soda to match the color, taste, and calorie content of OJ, but will contain no micronutrients.
This research will measure UV-induced skin erythema, wrinkles, smoothness, roughness, elasticity, hydration, pH, melanin, and transepidermal water loss (a skin barrier index) of skin on both face and forearm.
Skin strips and swabs will be collected and preserved for future assessments of skin lipids and colonized microorganisms (skin microbiome) because they are key factors affecting skin health.
Positive results from this pilot trial will provide clinical evidence on the effectiveness of OJ to maintain skin health and reduce ageing.
This research will be carried out by a research team with the experience and facilities for skin research.
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yavuz Yagiz, PhD
- Phone Number: (352) 294-3988
- Email: yavuzy@ufl.edu
Study Contact Backup
- Name: Liwei Gu, PhD
- Phone Number: (352) 294-3730
- Email: lgu@ufl.edu
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32611
- Recruiting
- Food Science and Human Nutrition Department at University of Florida
-
Contact:
- Yavuz Yagiz
-
Contact:
- Liwe Gu
-
Principal Investigator:
- Liwei Gu, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- BMI (18.5-29.9)
- Body weight ≥110 pounds
- Fitzpatrick skin type 2 and 3.
Exclusion Criteria:
- pregnancy
- breast-feeding
- impaired fasting glucose
- frequent alcohol use
- history of skin cancer
- sunbathing and the use of tanning bed, intake of vitamin/mineral supplements
- habitual high intake of fruits (≥ 2 cups daily)
- intake of medication that might influence the outcome of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Orange Juice then Placebo juice (Fanta)
Participants will be provided orange juice for 84 days in this arm.
After 28 days wash-out period, participants will receive Fanta for 84 days.
|
Orange juice will be purchased commercially.
Fanta will be purchased commercially.
|
Active Comparator: Placebo (Fanta) then Orange juice
Participants will be provided Fanta for 84 days in this arm.
After 28 days wash-out period, participants will receive Orange juice for 84 days.
|
Orange juice will be purchased commercially.
Fanta will be purchased commercially.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline Skin color change after UV irradiation at 84 days
Time Frame: Baseline, 84 days
|
Irradiation will be applied to dorsal skin (back, scapular region not typically exposed to the sun) with 2 times of minimal erythema dose using an FDA approved UVB phototherapy light and a UV light meter.
At baseline, after 42 and 84 days, skin color will be measured before and 24 hours after irradiation.
Skin color will be evaluated by a colorimeter using the 3-dimensional color system with L*, a*, and b*-values.
L* and b* values assess lightness and browning effects, respectively.
The a*-value (red/green-axis) is a measure for reddening (erythema).
|
Baseline, 84 days
|
Change from baseline skin transepidermal water loss
Time Frame: Baseline, 84 days
|
Skin transepidermal water loss will be measured using a Tewameter to evaluate the water barrier function of the skin.
The Tewameter measures the density gradient of the water evaporation from the skin (g/h/m^2).
|
Baseline, 84 days
|
Change from baseline skin erythema and melanin index
Time Frame: Baseline, 84 days
|
Skin erythema and melanin index will be assessed with Mexameter.
These two components are mainly responsible for the color of the skin.
They are measured by reflectance.
|
Baseline, 84 days
|
Change from baseline skin pH plus
Time Frame: Baseline, 84 days
|
Skin pH will be measured using a Skin-pH-Meter.
|
Baseline, 84 days
|
Change from baseline skin hydration
Time Frame: Baseline, 84 days
|
Skin hydration will be measured using a Skin Corneometer.
|
Baseline, 84 days
|
Change in skin microbiome
Time Frame: Baseline, 84 days
|
For skin swabbing, a 3x3-cm square on a forearm will be swabbed with a cotton swab soaked in 0.9% sodium chloride with 0.1% Tween-20 in a Z-stroke manner.
|
Baseline, 84 days
|
Change in DNA damages
Time Frame: Baseline, 84 days
|
Urinary excretion of 8-oxo-2'-deoxyguanosine (8-oxo-dG) will be assessed using HPLC-MS/MS because it has been suggested as a sensitive marker for UV induced skin DNA damages.
|
Baseline, 84 days
|
Change in oxidative stress
Time Frame: Baseline, 84 days
|
Malondialdehyde in plasma will be determined as a marker of lipid peroxidation using a photometric method.
|
Baseline, 84 days
|
Change in inflammation
Time Frame: Baseline, 84 days
|
Plasma levels of IL-6 proteins will be analyzed as inflammation biomarkers using ELISA kits.
|
Baseline, 84 days
|
Change in inflammation
Time Frame: Baseline, 84 days
|
Plasma levels of C-reactive proteins will be analyzed as inflammation biomarkers using ELISA kits.
|
Baseline, 84 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Heinrich U, Moore CE, De Spirt S, Tronnier H, Stahl W. Green tea polyphenols provide photoprotection, increase microcirculation, and modulate skin properties of women. J Nutr. 2011 Jun;141(6):1202-8. doi: 10.3945/jn.110.136465. Epub 2011 Apr 27.
- Heinrich U, Neukam K, Tronnier H, Sies H, Stahl W. Long-term ingestion of high flavanol cocoa provides photoprotection against UV-induced erythema and improves skin condition in women. J Nutr. 2006 Jun;136(6):1565-9. doi: 10.1093/jn/136.6.1565.
- Li R, Kim MH, Sandhu AK, Gao C, Gu L. Muscadine Grape (Vitis rotundifolia) or Wine Phytochemicals Reduce Intestinal Inflammation in Mice with Dextran Sulfate Sodium-Induced Colitis. J Agric Food Chem. 2017 Feb 1;65(4):769-776. doi: 10.1021/acs.jafc.6b03806. Epub 2017 Jan 23.
- Heckman CJ, Chandler R, Kloss JD, Benson A, Rooney D, Munshi T, Darlow SD, Perlis C, Manne SL, Oslin DW. Minimal Erythema Dose (MED) testing. J Vis Exp. 2013 May 28;(75):e50175. doi: 10.3791/50175.
- Manippa V, Padulo C, van der Laan LN, Brancucci A. Gender Differences in Food Choice: Effects of Superior Temporal Sulcus Stimulation. Front Hum Neurosci. 2017 Dec 7;11:597. doi: 10.3389/fnhum.2017.00597. eCollection 2017.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 4, 2023
Primary Completion (Estimated)
October 1, 2024
Study Completion (Estimated)
December 1, 2024
Study Registration Dates
First Submitted
April 20, 2021
First Submitted That Met QC Criteria
April 26, 2021
First Posted (Actual)
April 27, 2021
Study Record Updates
Last Update Posted (Actual)
February 7, 2024
Last Update Submitted That Met QC Criteria
February 6, 2024
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB202100814
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Health
-
ESM Technologies, LLCEnrolling by invitationSkin Elasticity | Skin Hydration | Hair Health | Skin Barrier to Water Loss | Fingernail HealthUnited States
-
Manuka HealthCitruslabsActive, not recruiting
-
Thu BruléCitruslabsCompleted
-
PharmanexDermatology Consulting Services, High Point NCCompletedSkin HealthUnited States
-
Mundipharma Manufacturing Pte Ltd.Genome Institute of SingaporeCompleted
-
Manuka HealthCitruslabsActive, not recruiting
-
Johns Hopkins UniversityWithdrawn
-
Vedic Lifesciences Pvt. Ltd.Completed
-
PharmanexDermatology Consulting Services, High Point NCCompletedSkin HealthUnited States
-
Kimberly-Clark CorporationCompleted
Clinical Trials on Orange juice
-
PepsiCo Global R&DCompletedDigestive HealthUnited States
-
PepsiCo Global R&DCompletedGlycemic ResponseUnited States
-
Loma Linda UniversityCompletedBlood PressureUnited States
-
University of ReadingCompleted
-
Quadram Institute BioscienceBiotechnology and Biological Sciences Research Council; European CommissionCompleted
-
Hasselt UniversityHochschule Geisenheim UniversityUnknown
-
TNOCompletedInflammation | Alcohol ConsumptionNetherlands
-
Rutgers, The State University of New JerseyCompleted
-
University of HohenheimCompleted
-
University of Nevada, RenoUnited States Department of Agriculture (USDA); Sierra Nevada Nephrology Consultants...Enrolling by invitationHyperkalemia | Chronic Kidney Disease Requiring Chronic DialysisUnited States